{"gene":"ATP8B2","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2010,"finding":"ATP8B2 co-immunoprecipitates with CDC50A and CDC50B, and association with CDC50A increases ATP8B2 plasma membrane abundance; phosphorylation of the catalytically important Asp residue in ATP8B2 is critically dependent on its CDC50 subunit, establishing CDC50 proteins as integral components of the P4-ATPase flippase machinery required for ER export and catalytic activity.","method":"Co-immunoprecipitation, ER export assay, phosphorylation assay (catalytic Asp mutant)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP and functional phosphorylation assay replicated across two independent labs (PMID:20961850 and PMID:20947505) with orthogonal methods","pmids":["20961850","20947505"],"is_preprint":false},{"year":2010,"finding":"ATP8B2 partially localizes to the plasma membrane even without CDC50 co-expression, but displays a large increase in plasma membrane abundance upon CDC50A co-expression; subcellular localization of the P4-ATPase/CDC50 complex is determined by the P4-ATPase subunit, not the CDC50 protein.","method":"Immunofluorescence, co-expression, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional consequence (ER exit), single lab, two orthogonal methods","pmids":["20947505"],"is_preprint":false},{"year":2014,"finding":"ATP8B2, localized at the plasma membrane, exhibits preferential phospholipid flippase activity toward phosphatidylcholine (PC); ATPase-deficient mutants of related P4-ATPases lose flippase activity, indicating ATP8B2 flips PC in an ATPase-dependent manner.","method":"Phospholipid flippase activity assay using fluorescent lipid analogs in stable cell lines; ATPase-deficient mutant analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro/cell-based flippase assay with ATPase-deficient mutant controls, replicated in subsequent study (PMID:25947375)","pmids":["25315773","25947375"],"is_preprint":false},{"year":2022,"finding":"ATP8B2 knockdown enhances localization of plasmalogens (but not phosphatidylethanolamine) in the extracellular leaflet of the plasma membrane, impairs plasmalogen-dependent degradation of FAR1 (the rate-limiting enzyme for plasmalogen biosynthesis), and reduces AKT phosphorylation, leading to suppression of cell growth; ATP8B2 is thus responsible for enriching plasmalogens in the cytoplasmic leaflet and is required for plasmalogen homeostasis and AKT signaling.","method":"siRNA knockdown, fluorescent lipid analog localization assay, Western blotting (FAR1 stability, AKT phosphorylation), cell growth assay","journal":"Frontiers in molecular biosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD with defined cellular phenotype and multiple downstream readouts, single lab","pmids":["35832735"],"is_preprint":false},{"year":2024,"finding":"ATP8B2 (together with ATP8B1) can translocate phosphatidylinositol at the plasma membrane in addition to PC; double KO of ATP8B1/ATP8B2 accelerates depletion of PtdIns(4,5)P2 upon Gq-coupled receptor activation, indicating these flippases maintain phosphoinositide homeostasis at the plasma membrane.","method":"Knockout cell lines (CDC50A KO, ATP8B1/ATP8B2 double KO), fluorescent lipid analog flippase assay, live-cell PtdIns(4,5)P2 biosensor imaging","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with functional phosphoinositide readout, single lab, two orthogonal methods","pmids":["39258799"],"is_preprint":false},{"year":2015,"finding":"Gene silencing of ATP8B2 in pancreatic beta cells inhibited glucose-stimulated insulin secretion; ATP8B1 and CDC50A were highly concentrated in insulin secretory granules, supporting a role for P4-ATPase flippase activity in facilitating docking and fusion of insulin secretory granules to the plasma membrane.","method":"siRNA gene silencing, glucose-stimulated insulin secretion assay in purified beta cells and human pancreatic islets","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD with specific secretion phenotype, single lab, functional readout in two cell systems","pmids":["26240149"],"is_preprint":false},{"year":2025,"finding":"Knockdown of ATP8B2 in macrophages/foam cells inhibits autophagic flux (abnormal accumulation of LC3-II and p62), impairs degradation of oxidized LDL (ox-LDL), decreases mitochondrial membrane potential, and leads to mitochondrial dysfunction.","method":"siRNA knockdown, Western blotting (LC3-II, p62), immunofluorescence, JC-1 mitochondrial membrane potential assay, ox-LDL degradation assay","journal":"Cell biochemistry and biophysics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single knockdown approach without rescue experiment or mechanistic dissection of how phospholipid flipping connects to autophagy","pmids":["40148707"],"is_preprint":false},{"year":2025,"finding":"Knockdown of ATP8B2 in THP-1-derived foam cells impairs lysosomal membrane fusion (evidenced by increase in CD63-positive compartments without change in CD63 protein levels) and causes accumulation of autophagosomes under starvation, indicating a defect in the autophagy-lysosomal pathway.","method":"siRNA knockdown, immunofluorescence (CD63), Western blotting, autophagosome quantification","journal":"Molecular biology reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single knockdown approach, cellular phenotype without direct mechanistic link to flippase activity","pmids":["40402302"],"is_preprint":false},{"year":2020,"finding":"Global knockout of Atp8b2 in mice resulted in abnormal bone phenotypes, implicating ATP8B2 function in osteoclast-mediated bone mass regulation within a co-regulated macrophage multinucleation network (MMnet).","method":"Global knockout mouse model, bone phenotype analysis","journal":"eLife","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single KO phenotype, no direct molecular mechanism for ATP8B2 established in this study","pmids":["32553114"],"is_preprint":false}],"current_model":"ATP8B2 is a plasma membrane-localized class-1 P4-ATPase (phospholipid flippase) that, in complex with CDC50A or CDC50B (required for ER export and catalytic Asp phosphorylation), uses ATP hydrolysis to translocate phosphatidylcholine, plasmalogens, and phosphatidylinositol from the exoplasmic to the cytoplasmic leaflet of the plasma membrane, thereby maintaining membrane lipid asymmetry, plasmalogen homeostasis, and phosphoinositide levels, with functional consequences including AKT signaling, insulin secretion, autophagy/lysosomal membrane fusion, and bone homeostasis."},"narrative":{"mechanistic_narrative":"ATP8B2 is a plasma membrane class-1 P4-ATPase (phospholipid flippase) that translocates phospholipids from the exoplasmic to the cytoplasmic leaflet to maintain membrane lipid asymmetry [PMID:25315773, PMID:25947375]. Its activity and trafficking depend on the CDC50 accessory subunits CDC50A and CDC50B: CDC50 association is required for ER export and for phosphorylation of the catalytically essential Asp residue, and CDC50A co-expression markedly increases ATP8B2 plasma membrane abundance, while the P4-ATPase subunit itself dictates the localization of the complex [PMID:20961850, PMID:20947505]. ATP8B2 preferentially flips phosphatidylcholine in an ATPase-dependent manner [PMID:25315773, PMID:25947375], and also enriches plasmalogens in the cytoplasmic leaflet, where it controls plasmalogen homeostasis through plasmalogen-dependent degradation of the biosynthetic enzyme FAR1 and supports AKT phosphorylation and cell growth [PMID:35832735]. Together with ATP8B1 it additionally translocates phosphatidylinositol and sustains plasma membrane PtdIns(4,5)P2 levels upon Gq-coupled receptor activation [PMID:39258799]. These lipid-handling functions are linked to glucose-stimulated insulin secretion in pancreatic beta cells, where the flippase machinery localizes to insulin secretory granules [PMID:26240149].","teleology":[{"year":2010,"claim":"Established that ATP8B2 is not an autonomous enzyme but requires a CDC50 partner, defining the subunit composition of the functional flippase and the determinant of its plasma membrane delivery.","evidence":"Co-IP, ER export assay, and catalytic Asp phosphorylation assay in co-expression systems","pmids":["20961850","20947505"],"confidence":"High","gaps":["Did not resolve the relative physiological roles of CDC50A versus CDC50B","No structural model of the ATP8B2/CDC50 complex"]},{"year":2010,"claim":"Showed the P4-ATPase subunit, not CDC50, dictates where the complex resides, answering whether targeting information is carried by the catalytic or accessory subunit.","evidence":"Immunofluorescence, co-expression, and subcellular fractionation","pmids":["20947505"],"confidence":"Medium","gaps":["Targeting motif within ATP8B2 not mapped","Single-lab observation"]},{"year":2014,"claim":"Identified the substrate specificity of ATP8B2 as phosphatidylcholine and demonstrated catalytic dependence, moving from a putative flippase to a defined PC-translocating enzyme.","evidence":"Fluorescent lipid analog flippase assay in stable cell lines with ATPase-deficient mutant controls","pmids":["25315773","25947375"],"confidence":"High","gaps":["Did not establish full substrate repertoire beyond PC","Kinetics and selectivity relative to other P4-ATPases not quantified"]},{"year":2015,"claim":"Connected flippase activity to a physiological secretory process by showing ATP8B2 is needed for glucose-stimulated insulin secretion.","evidence":"siRNA silencing and glucose-stimulated insulin secretion assays in beta cells and human islets","pmids":["26240149"],"confidence":"Medium","gaps":["Mechanistic link between lipid flipping and granule docking/fusion not directly demonstrated","Relative contribution of ATP8B2 versus ATP8B1 in granules unresolved"]},{"year":2022,"claim":"Extended substrate range to plasmalogens and linked ATP8B2 to a lipid-homeostatic feedback loop and AKT-dependent growth, explaining a downstream signaling consequence of leaflet asymmetry.","evidence":"siRNA knockdown with fluorescent lipid localization, FAR1 stability and AKT phosphorylation Western blots, and growth assays","pmids":["35832735"],"confidence":"Medium","gaps":["Direct biochemical flipping of plasmalogens not reconstituted","How leaflet asymmetry mechanistically couples to AKT not defined","Single-lab study"]},{"year":2024,"claim":"Broadened ATP8B2 function to phosphoinositide homeostasis, showing it (with ATP8B1) maintains plasma membrane PtdIns(4,5)P2 during receptor signaling.","evidence":"CDC50A and ATP8B1/ATP8B2 double-knockout cells with flippase assays and live-cell PtdIns(4,5)P2 biosensor imaging","pmids":["39258799"],"confidence":"Medium","gaps":["Direct flipping of phosphoinositides versus indirect effects not fully separated","Redundancy with ATP8B1 limits attribution to ATP8B2 alone"]},{"year":2020,"claim":"First in vivo loss-of-function evidence implicated ATP8B2 in osteoclast-mediated bone mass regulation.","evidence":"Global Atp8b2 knockout mouse with bone phenotype analysis","pmids":["32553114"],"confidence":"Low","gaps":["No molecular mechanism linking flippase activity to bone phenotype established in this study","Cell-type-specific contribution not dissected"]},{"year":2025,"claim":"Associated ATP8B2 loss with defects in the autophagy-lysosomal pathway and mitochondrial function in macrophage/foam cell models.","evidence":"siRNA knockdown with LC3-II/p62 and CD63 readouts, ox-LDL degradation, autophagosome quantification, and JC-1 mitochondrial potential assays","pmids":["40148707","40402302"],"confidence":"Low","gaps":["No rescue experiment and no direct mechanistic link from phospholipid flipping to autophagy/lysosomal fusion","Single knockdown approach in a single cell model"]},{"year":null,"claim":"How ATP8B2-driven leaflet asymmetry is mechanistically transduced into downstream signaling, secretion, and membrane fusion events remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of the ATP8B2/CDC50 complex","Causal chain from specific lipid substrates to AKT, insulin granule fusion, and autophagy not reconstituted","No human disease mutation linked to ATP8B2 in the available corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,2]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[2,3,4]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,2,4]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,3,4]}],"complexes":[],"partners":["CDC50A","CDC50B","ATP8B1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P98198","full_name":"Phospholipid-transporting ATPase ID","aliases":["ATPase class I type 8B member 2","P4-ATPase flippase complex alpha subunit ATP8B2"],"length_aa":1209,"mass_kda":137.4,"function":"Catalytic component of P4-ATPase flippase complex, which catalyzes the hydrolysis of ATP coupled to the transport of phosphatidylcholine (PC) from the outer to the inner leaflet of the plasma membrane. May contribute to the maintenance of membrane lipid asymmetry","subcellular_location":"Cell membrane; Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/P98198/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP8B2","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ATP8B2","total_profiled":1310},"omim":[{"mim_id":"605867","title":"ATPase, CLASS I, TYPE 8B, MEMBER 2; ATP8B2","url":"https://www.omim.org/entry/605867"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ATP8B2"},"hgnc":{"alias_symbol":["ATPID","KIAA1137"],"prev_symbol":[]},"alphafold":{"accession":"P98198","domains":[{"cath_id":"2.70.150.10","chopping":"32-51_150-276","consensus_level":"high","plddt":87.736,"start":32,"end":276},{"cath_id":"-","chopping":"284-356","consensus_level":"medium","plddt":85.9618,"start":284,"end":356},{"cath_id":"3.40.50.1000","chopping":"369-414_672-742_767-868","consensus_level":"high","plddt":87.7034,"start":369,"end":868},{"cath_id":"3.40.1110.10","chopping":"421-440_450-669","consensus_level":"high","plddt":88.5956,"start":421,"end":669},{"cath_id":"-","chopping":"882-1112","consensus_level":"medium","plddt":89.1252,"start":882,"end":1112},{"cath_id":"1.10.287","chopping":"61-126","consensus_level":"high","plddt":82.6535,"start":61,"end":126}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P98198","model_url":"https://alphafold.ebi.ac.uk/files/AF-P98198-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P98198-F1-predicted_aligned_error_v6.png","plddt_mean":81.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP8B2","jax_strain_url":"https://www.jax.org/strain/search?query=ATP8B2"},"sequence":{"accession":"P98198","fasta_url":"https://rest.uniprot.org/uniprotkb/P98198.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P98198/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P98198"}},"corpus_meta":[{"pmid":"33111402","id":"PMC_33111402","title":"Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.","date":"2020","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/33111402","citation_count":134,"is_preprint":false},{"pmid":"20961850","id":"PMC_20961850","title":"CDC50 proteins are critical components of the human class-1 P4-ATPase transport machinery.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20961850","citation_count":128,"is_preprint":false},{"pmid":"20947505","id":"PMC_20947505","title":"Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4-ATPases.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20947505","citation_count":109,"is_preprint":false},{"pmid":"25315773","id":"PMC_25315773","title":"Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25315773","citation_count":104,"is_preprint":false},{"pmid":"25947375","id":"PMC_25947375","title":"Phospholipid Flippase ATP10A Translocates Phosphatidylcholine and Is Involved in Plasma Membrane Dynamics.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25947375","citation_count":72,"is_preprint":false},{"pmid":"26240149","id":"PMC_26240149","title":"Characterization of P4 ATPase Phospholipid Translocases (Flippases) in Human and Rat Pancreatic Beta Cells: THEIR GENE SILENCING INHIBITS INSULIN SECRETION.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26240149","citation_count":25,"is_preprint":false},{"pmid":"32553114","id":"PMC_32553114","title":"A trans-eQTL network regulates osteoclast multinucleation and bone mass.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32553114","citation_count":24,"is_preprint":false},{"pmid":"12880872","id":"PMC_12880872","title":"FIC1, a P-type ATPase linked to cholestatic liver disease, has homologues (ATP8B2 and ATP8B3) expressed throughout the body.","date":"2003","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12880872","citation_count":22,"is_preprint":false},{"pmid":"35832735","id":"PMC_35832735","title":"ATP8B2-Mediated Asymmetric Distribution of Plasmalogens Regulates Plasmalogen Homeostasis and Plays a Role in Intracellular Signaling.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/35832735","citation_count":15,"is_preprint":false},{"pmid":"37755186","id":"PMC_37755186","title":"Asymmetric Distribution of Plasmalogens and Their Roles-A Mini Review.","date":"2023","source":"Membranes","url":"https://pubmed.ncbi.nlm.nih.gov/37755186","citation_count":10,"is_preprint":false},{"pmid":"39258799","id":"PMC_39258799","title":"Novel phosphatidylinositol flippases contribute to phosphoinositide homeostasis in the plasma membrane.","date":"2024","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/39258799","citation_count":9,"is_preprint":false},{"pmid":"26299976","id":"PMC_26299976","title":"Application of human haploid cell genetic screening model in identifying the genes required for resistance to environmental toxicants: Chlorpyrifos as a case study.","date":"2015","source":"Journal of pharmacological and toxicological methods","url":"https://pubmed.ncbi.nlm.nih.gov/26299976","citation_count":8,"is_preprint":false},{"pmid":"31633210","id":"PMC_31633210","title":"An association analysis for 14 candidate genes mapping to meat quality quantitative trait loci in a Duroc pig population reveals that the ATP1A2 genotype is highly associated with muscle electric conductivity.","date":"2019","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31633210","citation_count":7,"is_preprint":false},{"pmid":"37843347","id":"PMC_37843347","title":"Construction of molecular subgroups of ulcerative colitis.","date":"2023","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37843347","citation_count":2,"is_preprint":false},{"pmid":"40148707","id":"PMC_40148707","title":"Down-regulation of ATP8B2 in Foam Cells Inhibits Autophagic Flux and ox-LDL Degradation in Atherosclerosis.","date":"2025","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/40148707","citation_count":1,"is_preprint":false},{"pmid":"38977599","id":"PMC_38977599","title":"Downregulation of ATP8B2 to Assess Plasmalogen Distribution and Far1 Expression in Primary Trabecular Meshwork Cells.","date":"2024","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/38977599","citation_count":0,"is_preprint":false},{"pmid":"40402302","id":"PMC_40402302","title":"Downregulation of ATP8B2 in atherosclerosis exacerbates foam cell-like pathological changes via impairing lysosomal membrane fusion.","date":"2025","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/40402302","citation_count":0,"is_preprint":false},{"pmid":"41363690","id":"PMC_41363690","title":"Weighted Burden Analysis of Rare Genetic Variants Identifies Novel Genes with Effects on BMI.","date":"2025","source":"Human heredity","url":"https://pubmed.ncbi.nlm.nih.gov/41363690","citation_count":0,"is_preprint":false},{"pmid":"37291913","id":"PMC_37291913","title":"[Genotype-environment interaction on arterial stiffness: A pedigree-based study].","date":"2023","source":"Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37291913","citation_count":0,"is_preprint":false},{"pmid":"42108926","id":"PMC_42108926","title":"Identification and Validation of Mitophagy-Related Biomarkers in Colorectal Cancer: An Integrated Analysis of Single-Cell Transcriptome and Mendelian Randomization.","date":"2026","source":"Genetics research","url":"https://pubmed.ncbi.nlm.nih.gov/42108926","citation_count":0,"is_preprint":false},{"pmid":"41555830","id":"PMC_41555830","title":"Phospholipid Interconversion and Transport Are Altered in Glaucoma.","date":"2026","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/41555830","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12341,"output_tokens":2231,"usd":0.035244,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9322,"output_tokens":2935,"usd":0.059992,"stage2_stop_reason":"end_turn"},"total_usd":0.095236,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"ATP8B2 co-immunoprecipitates with CDC50A and CDC50B, and association with CDC50A increases ATP8B2 plasma membrane abundance; phosphorylation of the catalytically important Asp residue in ATP8B2 is critically dependent on its CDC50 subunit, establishing CDC50 proteins as integral components of the P4-ATPase flippase machinery required for ER export and catalytic activity.\",\n      \"method\": \"Co-immunoprecipitation, ER export assay, phosphorylation assay (catalytic Asp mutant)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP and functional phosphorylation assay replicated across two independent labs (PMID:20961850 and PMID:20947505) with orthogonal methods\",\n      \"pmids\": [\"20961850\", \"20947505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ATP8B2 partially localizes to the plasma membrane even without CDC50 co-expression, but displays a large increase in plasma membrane abundance upon CDC50A co-expression; subcellular localization of the P4-ATPase/CDC50 complex is determined by the P4-ATPase subunit, not the CDC50 protein.\",\n      \"method\": \"Immunofluorescence, co-expression, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional consequence (ER exit), single lab, two orthogonal methods\",\n      \"pmids\": [\"20947505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ATP8B2, localized at the plasma membrane, exhibits preferential phospholipid flippase activity toward phosphatidylcholine (PC); ATPase-deficient mutants of related P4-ATPases lose flippase activity, indicating ATP8B2 flips PC in an ATPase-dependent manner.\",\n      \"method\": \"Phospholipid flippase activity assay using fluorescent lipid analogs in stable cell lines; ATPase-deficient mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro/cell-based flippase assay with ATPase-deficient mutant controls, replicated in subsequent study (PMID:25947375)\",\n      \"pmids\": [\"25315773\", \"25947375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ATP8B2 knockdown enhances localization of plasmalogens (but not phosphatidylethanolamine) in the extracellular leaflet of the plasma membrane, impairs plasmalogen-dependent degradation of FAR1 (the rate-limiting enzyme for plasmalogen biosynthesis), and reduces AKT phosphorylation, leading to suppression of cell growth; ATP8B2 is thus responsible for enriching plasmalogens in the cytoplasmic leaflet and is required for plasmalogen homeostasis and AKT signaling.\",\n      \"method\": \"siRNA knockdown, fluorescent lipid analog localization assay, Western blotting (FAR1 stability, AKT phosphorylation), cell growth assay\",\n      \"journal\": \"Frontiers in molecular biosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD with defined cellular phenotype and multiple downstream readouts, single lab\",\n      \"pmids\": [\"35832735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ATP8B2 (together with ATP8B1) can translocate phosphatidylinositol at the plasma membrane in addition to PC; double KO of ATP8B1/ATP8B2 accelerates depletion of PtdIns(4,5)P2 upon Gq-coupled receptor activation, indicating these flippases maintain phosphoinositide homeostasis at the plasma membrane.\",\n      \"method\": \"Knockout cell lines (CDC50A KO, ATP8B1/ATP8B2 double KO), fluorescent lipid analog flippase assay, live-cell PtdIns(4,5)P2 biosensor imaging\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with functional phosphoinositide readout, single lab, two orthogonal methods\",\n      \"pmids\": [\"39258799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gene silencing of ATP8B2 in pancreatic beta cells inhibited glucose-stimulated insulin secretion; ATP8B1 and CDC50A were highly concentrated in insulin secretory granules, supporting a role for P4-ATPase flippase activity in facilitating docking and fusion of insulin secretory granules to the plasma membrane.\",\n      \"method\": \"siRNA gene silencing, glucose-stimulated insulin secretion assay in purified beta cells and human pancreatic islets\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD with specific secretion phenotype, single lab, functional readout in two cell systems\",\n      \"pmids\": [\"26240149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Knockdown of ATP8B2 in macrophages/foam cells inhibits autophagic flux (abnormal accumulation of LC3-II and p62), impairs degradation of oxidized LDL (ox-LDL), decreases mitochondrial membrane potential, and leads to mitochondrial dysfunction.\",\n      \"method\": \"siRNA knockdown, Western blotting (LC3-II, p62), immunofluorescence, JC-1 mitochondrial membrane potential assay, ox-LDL degradation assay\",\n      \"journal\": \"Cell biochemistry and biophysics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single knockdown approach without rescue experiment or mechanistic dissection of how phospholipid flipping connects to autophagy\",\n      \"pmids\": [\"40148707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Knockdown of ATP8B2 in THP-1-derived foam cells impairs lysosomal membrane fusion (evidenced by increase in CD63-positive compartments without change in CD63 protein levels) and causes accumulation of autophagosomes under starvation, indicating a defect in the autophagy-lysosomal pathway.\",\n      \"method\": \"siRNA knockdown, immunofluorescence (CD63), Western blotting, autophagosome quantification\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single knockdown approach, cellular phenotype without direct mechanistic link to flippase activity\",\n      \"pmids\": [\"40402302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Global knockout of Atp8b2 in mice resulted in abnormal bone phenotypes, implicating ATP8B2 function in osteoclast-mediated bone mass regulation within a co-regulated macrophage multinucleation network (MMnet).\",\n      \"method\": \"Global knockout mouse model, bone phenotype analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single KO phenotype, no direct molecular mechanism for ATP8B2 established in this study\",\n      \"pmids\": [\"32553114\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP8B2 is a plasma membrane-localized class-1 P4-ATPase (phospholipid flippase) that, in complex with CDC50A or CDC50B (required for ER export and catalytic Asp phosphorylation), uses ATP hydrolysis to translocate phosphatidylcholine, plasmalogens, and phosphatidylinositol from the exoplasmic to the cytoplasmic leaflet of the plasma membrane, thereby maintaining membrane lipid asymmetry, plasmalogen homeostasis, and phosphoinositide levels, with functional consequences including AKT signaling, insulin secretion, autophagy/lysosomal membrane fusion, and bone homeostasis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ATP8B2 is a plasma membrane class-1 P4-ATPase (phospholipid flippase) that translocates phospholipids from the exoplasmic to the cytoplasmic leaflet to maintain membrane lipid asymmetry [#2]. Its activity and trafficking depend on the CDC50 accessory subunits CDC50A and CDC50B: CDC50 association is required for ER export and for phosphorylation of the catalytically essential Asp residue, and CDC50A co-expression markedly increases ATP8B2 plasma membrane abundance, while the P4-ATPase subunit itself dictates the localization of the complex [#0, #1]. ATP8B2 preferentially flips phosphatidylcholine in an ATPase-dependent manner [#2], and also enriches plasmalogens in the cytoplasmic leaflet, where it controls plasmalogen homeostasis through plasmalogen-dependent degradation of the biosynthetic enzyme FAR1 and supports AKT phosphorylation and cell growth [#3]. Together with ATP8B1 it additionally translocates phosphatidylinositol and sustains plasma membrane PtdIns(4,5)P2 levels upon Gq-coupled receptor activation [#4]. These lipid-handling functions are linked to glucose-stimulated insulin secretion in pancreatic beta cells, where the flippase machinery localizes to insulin secretory granules [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Established that ATP8B2 is not an autonomous enzyme but requires a CDC50 partner, defining the subunit composition of the functional flippase and the determinant of its plasma membrane delivery.\",\n      \"evidence\": \"Co-IP, ER export assay, and catalytic Asp phosphorylation assay in co-expression systems\",\n      \"pmids\": [\n        \"20961850\",\n        \"20947505\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Did not resolve the relative physiological roles of CDC50A versus CDC50B\",\n        \"No structural model of the ATP8B2/CDC50 complex\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed the P4-ATPase subunit, not CDC50, dictates where the complex resides, answering whether targeting information is carried by the catalytic or accessory subunit.\",\n      \"evidence\": \"Immunofluorescence, co-expression, and subcellular fractionation\",\n      \"pmids\": [\n        \"20947505\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Targeting motif within ATP8B2 not mapped\",\n        \"Single-lab observation\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified the substrate specificity of ATP8B2 as phosphatidylcholine and demonstrated catalytic dependence, moving from a putative flippase to a defined PC-translocating enzyme.\",\n      \"evidence\": \"Fluorescent lipid analog flippase assay in stable cell lines with ATPase-deficient mutant controls\",\n      \"pmids\": [\n        \"25315773\",\n        \"25947375\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Did not establish full substrate repertoire beyond PC\",\n        \"Kinetics and selectivity relative to other P4-ATPases not quantified\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Connected flippase activity to a physiological secretory process by showing ATP8B2 is needed for glucose-stimulated insulin secretion.\",\n      \"evidence\": \"siRNA silencing and glucose-stimulated insulin secretion assays in beta cells and human islets\",\n      \"pmids\": [\n        \"26240149\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanistic link between lipid flipping and granule docking/fusion not directly demonstrated\",\n        \"Relative contribution of ATP8B2 versus ATP8B1 in granules unresolved\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended substrate range to plasmalogens and linked ATP8B2 to a lipid-homeostatic feedback loop and AKT-dependent growth, explaining a downstream signaling consequence of leaflet asymmetry.\",\n      \"evidence\": \"siRNA knockdown with fluorescent lipid localization, FAR1 stability and AKT phosphorylation Western blots, and growth assays\",\n      \"pmids\": [\n        \"35832735\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct biochemical flipping of plasmalogens not reconstituted\",\n        \"How leaflet asymmetry mechanistically couples to AKT not defined\",\n        \"Single-lab study\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Broadened ATP8B2 function to phosphoinositide homeostasis, showing it (with ATP8B1) maintains plasma membrane PtdIns(4,5)P2 during receptor signaling.\",\n      \"evidence\": \"CDC50A and ATP8B1/ATP8B2 double-knockout cells with flippase assays and live-cell PtdIns(4,5)P2 biosensor imaging\",\n      \"pmids\": [\n        \"39258799\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct flipping of phosphoinositides versus indirect effects not fully separated\",\n        \"Redundancy with ATP8B1 limits attribution to ATP8B2 alone\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"First in vivo loss-of-function evidence implicated ATP8B2 in osteoclast-mediated bone mass regulation.\",\n      \"evidence\": \"Global Atp8b2 knockout mouse with bone phenotype analysis\",\n      \"pmids\": [\n        \"32553114\"\n      ],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No molecular mechanism linking flippase activity to bone phenotype established in this study\",\n        \"Cell-type-specific contribution not dissected\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Associated ATP8B2 loss with defects in the autophagy-lysosomal pathway and mitochondrial function in macrophage/foam cell models.\",\n      \"evidence\": \"siRNA knockdown with LC3-II/p62 and CD63 readouts, ox-LDL degradation, autophagosome quantification, and JC-1 mitochondrial potential assays\",\n      \"pmids\": [\n        \"40148707\",\n        \"40402302\"\n      ],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No rescue experiment and no direct mechanistic link from phospholipid flipping to autophagy/lysosomal fusion\",\n        \"Single knockdown approach in a single cell model\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ATP8B2-driven leaflet asymmetry is mechanistically transduced into downstream signaling, secretion, and membrane fusion events remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structure of the ATP8B2/CDC50 complex\",\n        \"Causal chain from specific lipid substrates to AKT, insulin granule fusion, and autophagy not reconstituted\",\n        \"No human disease mutation linked to ATP8B2 in the available corpus\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0140657\",\n        \"supporting_discovery_ids\": [\n          0,\n          2\n        ]\n      },\n      {\n        \"term_id\": \"GO:0140359\",\n        \"supporting_discovery_ids\": [\n          2,\n          4\n        ]\n      },\n      {\n        \"term_id\": \"GO:0008289\",\n        \"supporting_discovery_ids\": [\n          2,\n          3,\n          4\n        ]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0005886\",\n        \"supporting_discovery_ids\": [\n          1,\n          2,\n          4\n        ]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"R-HSA-1430728\",\n        \"supporting_discovery_ids\": [\n          2,\n          3,\n          4\n        ]\n      }\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CDC50A\",\n      \"CDC50B\",\n      \"ATP8B1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}